Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Phenomenex to join Danaher portfolio
by Marc S. Reisch
October 17, 2016
| A version of this story appeared in
Volume 94, Issue 41
Danaher will acquire Phenomenex, a maker of chromatography columns with about 700 employees. The acquisition is intended to strengthen the instrumentation and consumables portfolio of the industrial conglomerate. Financial details were not disclosed, but Goldman Sachs estimates that Phenomenex has annual sales of about $200 million. Danaher says Phenomenex will continue to operate as a stand-alone company once the deal closes later this year. Other Danaher-owned instrument firms include Sciex, Beckman Coulter Life Sciences, and Molecular Devices.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter